Leukapheresis is a procedure used to treat chronic lymphocytic leukemia (CLL) or patients with very high white blood cell counts. Leukemia starts in early forms of blood cells, usually white blood cells or leucocytes, which helps to fight against infections caused by foreign particles.

The leukapheresis devices market is estimated to be valued at US$ 22.32 million in 2020 and is expected to exhibit a CAGR of 7.6% during the forecast period (2020-2027).

Request for Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/4142

Increasing incidence of leukemia and number of blood donations are expected to drive the market growth over the forecast period
According to the International Agency for Research on Cancer (IARC), in 2018, around 437,033 cases of leukemia were registered and 309,006 deaths occurred due to leukemia, globally.
The need for blood and blood products is increasing every year in many countries - particularly low and middle income countries. Transfusion of blood and blood products help patients suffering from life-threatening conditions to live longer and maintain a higher quality of life, and it supports complex medical and surgical procedures.
According to the American National Red Cross 2020, around 21 million blood components are transfused each year in the U.S.

Leukapheresis Market- Restraints
However, high cost associated with apheresis procedure and devices are major factors that hinder growth of the market. For instance, in the U.S., the cost of an apheresis procedure is around US$ 2,500 per treatment, which is very high. Furthermore, in India, the apheresis machine costs US$ 23,459 and there is an apheresis kit, which is required for separating components costing around US$ 134, which is very costly for low-income individuals to afford.

Leukapheresis Market– Regional Analysis
North America accounted for the largest share in the leukapheresis devices market in 2019, owing to increasing prevalence and incidence of leukemia in this region. According to Leukemia and Lymphoma Society (LLS), in 2019, around 61,780 people were diagnosed with leukemia. According to Leukemia and Lymphoma Society and American Cancer Society, from 2011-2015, in the U.S., leukemia was the sixth most common cause of cancer death in both men and women.

Furthermore, Asia Pacific is expected to witness the fastest growth during the forecast period. Owing to increasing geriatric population and health expenditure. For instance, according to the Population Census 2011, there were around 104 million elderly persons (aged 60 years or above) in India; 53 million females and 51 million males, and is expected to reach 173 million by 2026 in India.
Leukapheresis Market- Competitive Landscape

Key players operating in the leukapheresis devices market include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, and Key Biologics, LLC.

Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/4142

Key features of the study:
• This report provides in-depth analysis of the global leukapheresis devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global leukapheresis devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, and Key Biologics, LLC
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
• The global leukapheresis devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for leukapheresis devices market, research and consulting firms, new entrants, and financial analysts

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: [email protected]